A Within-Trial Economic Evaluation of a Patient Navigator Program in Children With CKD
W. T. Chen(UNSW Sydney), Andrea N. Natsky(The University of Sydney), Charani Kiriwandeniya(The University of Queensland), Nicholas Larkins, Simon Carter(Royal Children's Hospital), Seán Kennedy(Environmental Protection Agency), Germaine Wong(Children's Hospital at Westmead), Patrina Caldwell(Children's Hospital at Westmead), Siah Kim
Cited by 1
Related Papers
Overview of a workshop on screening methods for detecting potential (anti-) estrogenic/androgenic chemicals in wildlife
|Environmental Toxicology and Chemistry|1998|288
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes
|Kidney International|2017|184
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
|American Journal of Kidney Diseases|2021|167
Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
|The Journal of Pediatrics|2014|151